In experiments with mice it has been found that an existing drug, zileuton, can be useful to block the production of molecules that are related to dementia. Mice receiving the drug did significantly better in maze memory tests than those that did not. Inflammation and damage to the brain were reversed. Human tests have to be done in order to see whether the results translate to human Alzheimer's patients.